ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ANABEL LOPEZ-RIVERA M.D.

SAN ALFONSO A-7 AVE DEGETAU

Caguas | Puerto Rico | 00725

(787) 502-3590

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Ambulatory Health Care Facilities, Adult Mental Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,533Medicare Part D Prescriptions Filled, Including Refills
$238K Total Retail Price of All Prescriptions
519 Patients Receiving at Least One Drug in Part D
38%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
TRAZODONE HCL 536 120
RISPERIDONE 502 281
PAROXETINE HCL 496 169
CITALOPRAM HBR 371 158
SERTRALINE HCL 364 157
LAMOTRIGINE 287 27
BUPROPION HCL SR 232 89
ZOLPIDEM TARTRATE 229 121
MIRTAZAPINE 228 66
FLUOXETINE HCL 178 34
BUPROPION XL 174 35
AMITRIPTYLINE HCL 152 11 R
HALOPERIDOL 141 30
VENLAFAXINE HCL ER 104 21
LITHIUM CARBONATE 93 14
QUETIAPINE FUMARATE 90 38
OLANZAPINE 81 28
VENLAFAXINE HCL 80 14
CLOZAPINE 80 13
ZALEPLON 75 29
DIPHENHYDRAMINE HCL 73 14 R
DIVALPROEX SODIUM 66 0
CYMBALTA 62 37
DOXEPIN HCL 60 0
BENZTROPINE MESYLATE 56 0 R
SEROQUEL 54 30
ABILIFY 51 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.